• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pediatr Pulmonol . Clinical features and follow-up of pediatric patients hospitalized for COVID-19

tetano

Editor, Senior Moderator
Pediatr Pulmonol


. 2021 Apr 14.
doi: 10.1002/ppul.25407. Online ahead of print.
Clinical features and follow-up of pediatric patients hospitalized for COVID-19


Feng Tang[SUP] 1 [/SUP], Wanjun Luo[SUP] 1 [/SUP], Xiaowen Wang[SUP] 1 [/SUP], Hui Li[SUP] 1 [/SUP], Hong Mei[SUP] 1 [/SUP], Jianbo Shao[SUP] 1 [/SUP], Qifa Song[SUP] 2 [/SUP]



Affiliations

Abstract

Objective: This report summarizes the clinical features and 1-month follow-up observations for pediatric patients who were hospitalized with coronavirus disease 2019 (COVID-19) in Wuhan Women and Children's Hospital.
Methods: The 1-month follow-up data included clinical manifestations and results from serum severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG and IgM tests, reverse-transcription polymerase chain reaction (RT-PCR) for SARS-CoV-2, lung computed tomography (CT) scans, and laboratory tests.
Results: Between January 20 and March 15, 2020, 127 patients aged 0-15 years were hospitalized for COVID-19 treatment, including 3 severe cases and 124 mild or moderate cases. The main therapies included inhalation of aerosolized interferon-? (122/127) and additional antiviral drugs (28/127). Among the 81 patients who had pneumonia at admission, 35 with right lobe pneumonia had the longest hospital stay (mean 14.5 ? 7 days); 17 with left lobe pneumonia had the highest creatine kinase (154 ? 106 U/L) and creatine kinase myocardial band (CK-MB, 43 ? 48 U/L) levels; and 29 with bilateral pneumonia had the highest white blood cell counts (8.3 ? 4 ? 10[SUP]9[/SUP] /L). Among the 46 patients who were successfully followed up 1 month after discharge, two notable findings were right lobe pneumonia in 22% (95% confidence interval [CI]: 11%-37%) of patients and persistently elevated serum creatine kinase and CK-MB levels. The median duration of elevated CK-MB was 45 days. The mean concentrations of serum SARS-CoV-2 IgG and IgM in 41 patients were 8.0 ? 7.5 and 98 ? 40 ng/ml, respectively. At follow-up, four patients retested positive for SARS-CoV-2.
Conclusions: The involvement of different lung lobes in patients with COVID-19 was associated with variations in the persistence of pneumonia and elevation of CK-MB levels and body temperature.

Keywords: coronavirus disease 2019 (COVID-19); follow-up; pediatric patients; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
 
Back
Top Bottom